Tag: corporate-moves
-
Exclusive: Pfizer weighs sale or spin-off of consumer health unit – sources
By Lauren Hirsch, Olivia Oran and Carl O'Donnell (Reuters) – U.S. drugmaker Pfizer Inc is evaluating a potential sale or spin-off of its consumer health division that could value the unit at as much as $14 billion, people familiar with the matter said on Wednesday. A Pfizer exit from the consumer health business, which includes…
-
Mylan working to finalize EpiPen Medicaid settlement: CFO
Generic drugmaker Mylan NV said on Wednesday it was working to finalize a settlement with the U.S. government over Medicaid rebates for its EpiPen emergency allergy treatment, adding that money set aside for the settlement led to a third quarter loss. The company had previously said it agreed to terms of a settlement set at…